Your browser doesn't support javascript.
loading
Multi-omics data integration methods and their applications in psychiatric disorders.
Sathyanarayanan, Anita; Mueller, Tamara T; Ali Moni, Mohammad; Schueler, Katja; Baune, Bernhard T; Lio, Pietro; Mehta, Divya; Baune, Bernhard T; Dierssen, Mara; Ebert, Bjarke; Fabbri, Chiara; Fusar-Poli, Paolo; Gennarelli, Massimo; Harmer, Catherine; Howes, Oliver D; Janzing, Joost G E; Lio, Pietro; Maron, Eduard; Mehta, Divya; Minelli, Alessandra; Nonell, Lara; Pisanu, Claudia; Potier, Marie-Claude; Rybakowski, Filip; Serretti, Alessandro; Squassina, Alessio; Stacey, David; van Westrhenen, Roos; Xicota, Laura.
Afiliação
  • Sathyanarayanan A; Queensland University of Technology, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Kelvin Grove, Queensland 4059, Australia.
  • Mueller TT; Institute for Artificial Intelligence and Informatics in Medicine, TU Munich, 80333 Munich, Germany.
  • Ali Moni M; Artificial Intelligence and Digital Health Data Science, School of Health and Rehabilitation Sciences, Faculty of Health and Behavioural Sciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Schueler K; Clinic for Psychosomatics, Hospital zum Heiligen Geist, Frankfurt am Main, Germany; Frankfurt Psychoanalytic Institute, Frankfurt am Main, Germany.
  • Baune BT; Department of Psychiatry and Psychotherapy, University of Münster, Germany; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Australia.
  • Lio P; Department of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.
  • Mehta D; Queensland University of Technology, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Kelvin Grove, Queensland 4059, Australia. Electronic address: divya.mehta@qut.edu.au.
  • Baune BT; Department of Psychiatry and Psychotherapy, University of Münster, Germany; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Australia.
  • Dierssen M; Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Ebert B; Medical Strategy & Communication, H. Lundbeck A/S, Valby, Denmark.
  • Fabbri C; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Fusar-Poli P; Early Psychosis: Intervention and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, King's College London, United Kingdom; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Gennarelli M; Department of Molecular and Translational Medicine, University of Brescia; Genetics Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Harmer C; Department of Psychiatry, University of Oxford, United Kingdom.
  • Howes OD; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Psychiatric Imaging, Medical Research Council Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom.
  • Janzing JGE; Department of Psychiatry, Radboudumc Nijmegen the Netherlands.
  • Lio P; Department of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.
  • Maron E; Department of Psychiatry, University of Tartu, Tartu, Estonia; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, United Kingdom; Documental Ltd, Tallin, Estonia; West Tallinn Central Hospital, Tallinn, Estonia.
  • Mehta D; Queensland University of Technology, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Kelvin Grove, Queensland 4059, Australia.
  • Minelli A; Department of Molecular and Translational Medicine, University of Brescia; Genetics Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Nonell L; MARGenomics, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
  • Pisanu C; Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
  • Potier MC; Paris Brain Institute ICM, Salpetriere Hospital, Paris, France.
  • Rybakowski F; Department of Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
  • Serretti A; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
  • Squassina A; Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
  • Stacey D; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • van Westrhenen R; Parnassia Psychiatric Institute, Amsterdam, the Netherlands; Department of Psychiatry and Neuropsychology, Faculty of Health and Sciences, Maastricht University, Maastricht, the Netherlands; Institute of Psychiatry, Psychology & Neuroscience (IoPPN) King's College London, United Kingdom.
  • Xicota L; Paris Brain Institute ICM, Salpetriere Hospital, Paris, France.
Eur Neuropsychopharmacol ; 69: 26-46, 2023 04.
Article em En | MEDLINE | ID: mdl-36706689

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Multiômica / Transtornos Mentais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Multiômica / Transtornos Mentais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article